The Food and Drug Administration (FDA) has updated the prescribing information for Nuplazid® (pimavanserin; Acadia Pharmaceuticals) to include additional administration instructions for patients who have difficulty swallowing the whole capsule.
Nuplazid is approved for the treatment of hallucinations and delusions associated with Parkinson disease psychosis. In addition to being swallowed whole, the updated labeling now states that the contents of Nuplazid capsules can be sprinkled over a tablespoon (15mL) of applesauce, yogurt, pudding, or a liquid nutritional supplement. The drug/food mixture must be consumed immediately without chewing and should not be stored for future use.
For more information visit nuplazid.com.
Nuplazid® [package insert]. San Diego, CA: Acadia Pharmaceuticals Inc; 2020.